Adaptive non-inferiority margins under observable non-constancy.

Area of Science:

• Clinical Trials Methodology
• Statistical Inference in Medicine
• Drug Development and Regulation

Background:

• Non-inferiority trials rely on the 'constancy' assumption: active-control effectiveness remains consistent across studies.
• Violation of this assumption risks incorrect decisions about drug efficacy, potentially approving inferior products or rejecting beneficial ones.
• The constancy assumption cannot be directly validated without a placebo and is rarely perfectly met in practice.

Purpose of the Study:

• To address the challenge of the violated constancy assumption in non-inferiority trials.
• To propose a method for specifying non-inferiority margins that account for predicted active-control effectiveness.
• To introduce adaptive non-inferiority margins that adjust for constancy violations during the trial.

Main Methods:

• Utilizing measurable predictors of active-control effectiveness to define targeted non-inferiority margins.
• Developing a pre-specified method to adapt the non-inferiority margin based on baseline or post-baseline characteristics in the active-control arm.
• Implementing adaptive margins to adjust for inevitable constancy violations in clinical trials.

Main Results:

• The proposed method allows for the specification of non-inferiority margins tailored to specific study populations.
• Adaptive margins can be adjusted post-study to account for observed constancy violations.
• The approach aims to maintain pre-specified levels of Type I error and statistical power despite constancy issues.

Conclusions:

• Adaptive non-inferiority margins offer a robust solution to the inherent challenge of the constancy assumption in clinical trials.
• This methodology enhances the reliability of non-inferiority trial outcomes and decision-making.
• The approach ensures that trial results accurately reflect the true comparative effectiveness of treatments.